ConTIPI Medical selects EVERSANA to support U.S. commercialization of non-surgical medical device ProVate for women with pelvic organ prolapse

Recent Press Releases

• EVERSANA Expands Global Commercialisation Operations With Berlin, Germany Office
• ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse
• EVERSANA Unveils TEDAVI, the Breakthrough Content Creation Hub to Transform Agency Marketing Models and Maximize Brand Impact
• Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
• EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate